BioStem Technologies, Inc.
BSEM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $78,556 | $214,709 | $226,792 | $227,361 |
| - Cash | $27,158 | $30,844 | $26,673 | $22,833 |
| + Debt | $3,387 | $3,589 | $4,306 | $4,501 |
| Enterprise Value | $54,785 | $187,454 | $204,425 | $209,029 |
| Revenue | $10,473 | $49,296 | $72,528 | $102,874 |
| % Growth | -78.8% | -32% | -29.5% | – |
| Gross Profit | $9,211 | $48,611 | $71,675 | $99,283 |
| % Margin | 87.9% | 98.6% | 98.8% | 96.5% |
| EBITDA | $1,526 | $173 | $5,303 | $8,562 |
| % Margin | 14.6% | 0.4% | 7.3% | 8.3% |
| Net Income | $761 | -$564 | $4,483 | $15,520 |
| % Margin | 7.3% | -1.1% | 6.2% | 15.1% |
| EPS Diluted | 0.03 | -0.034 | 0.17 | 0.68 |
| % Growth | 188.8% | -119.9% | -75% | – |
| Operating Cash Flow | – | $5,422 | $4,074 | $8,159 |
| Capital Expenditures | – | -$332 | -$165 | -$131 |
| Free Cash Flow | – | $5,090 | $3,909 | $8,028 |